Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.
Petrak RM, Skorodin NC, Van Hise NW, Fliegelman RM, Pinsky J, Didwania V, Anderson M, Diaz M, Shah K, Chundi VV, Hines DW, Harting BP, Sidwha K, Yu B, Brune P, Owaisi A, Beezhold D, Kent J, Vais D, Han A, Gowda N, Sahgal N, Silverman J, Stake J, Nepomuceno J, Heddurshetti R.
Petrak RM, et al. Among authors: harting bp.
Clin Transl Sci. 2021 Nov;14(6):2146-2151. doi: 10.1111/cts.12894. Epub 2021 Oct 27.
Clin Transl Sci. 2021.
PMID: 32918792
Free PMC article.